Computational and Mathematical Methods in Medicine

Computational and Mathematical Methods in Medicine / 2008 / Article

Original Article | Open Access

Volume 9 |Article ID 849418 | https://doi.org/10.1080/17486700701865661

C. Chiyaka, W. Garira, S. Dube, "Modelling Immune Response and Drug Therapy in Human Malaria Infection", Computational and Mathematical Methods in Medicine, vol. 9, Article ID 849418, 21 pages, 2008. https://doi.org/10.1080/17486700701865661

Modelling Immune Response and Drug Therapy in Human Malaria Infection

Received14 Dec 2006
Accepted12 Dec 2007

Abstract

A new intra-host model of malaria that describes the dynamics of the blood stages of the parasite and its interaction with red blood cells and immune effectors is proposed. Local and global stability of the disease free equilibrium are investigated. Conditions for existence and uniqueness of the endemic equilibrium are derived. An intra-host basic reproductive number is identified. We deduce that drugs based on inhibiting parasite production are more effective than those based on inhibiting merozoite invasion of erythrocytes. We extend the model to incorporate, in addition to immune response, drug therapy, following treatment with antimalarial drugs. Using stability analysis of the model, it is shown that infection can be eradicated within the host if the drug efficacy level exceeds a certain threshold value. It will persist if the efficacy is below this threshold. Numerical simulations are done to verify the analytic results and illustrate possible behaviour of the models.

Copyright © 2008 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views670
Downloads6206
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.